Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.657, 2012-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drug-eluting stents: the safest option?
Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. :
Access to resources
Recommend
Everolimus-eluting stent for prevention of restenosis
Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. :
Everolimus-eluting stent superior: the SPIRIT III trial
Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. :
Drug-eluting stents: the safest option?
Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. :
Everolimus-eluting stent edges ahead?
Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. :